These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15177130)

  • 1. Polymorphism in the promoter region of the apolipoprotein A5 gene is associated with an increased susceptibility for coronary artery disease.
    Szalai C; Keszei M; Duba J; Prohászka Z; Kozma GT; Császár A; Balogh S; Almássy Z; Fust G; Czinner A
    Atherosclerosis; 2004 Mar; 173(1):109-14. PubMed ID: 15177130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A genetic variant c.553G > T in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and altered triglyceride levels in a Chinese population.
    Tang Y; Sun P; Guo D; Ferro A; Ji Y; Chen Q; Fan L
    Atherosclerosis; 2006 Apr; 185(2):433-7. PubMed ID: 16046221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The apolipoprotein A5 -1131T>C promoter polymorphism in Koreans: association with plasma APOA5 and serum triglyceride concentrations, LDL particle size and coronary artery disease.
    Jang Y; Paik JK; Hyun YJ; Chae JS; Kim JY; Choi JR; Lee SH; Shin DJ; Ordovas JM; Lee JH
    Clin Chim Acta; 2009 Apr; 402(1-2):83-7. PubMed ID: 19159622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The -1131 T>C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study.
    Martinelli N; Trabetti E; Bassi A; Girelli D; Friso S; Pizzolo F; Sandri M; Malerba G; Pignatti PF; Corrocher R; Olivieri O
    Atherosclerosis; 2007 Apr; 191(2):409-17. PubMed ID: 16682041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein A5 gene promoter region T-1131C polymorphism associates with elevated circulating triglyceride levels and confers susceptibility for development of ischemic stroke.
    Havasi V; Szolnoki Z; Talián G; Bene J; Komlósi K; Maász A; Somogyvári F; Kondacs A; Szabó M; Fodor L; Bodor A; Melegh B
    J Mol Neurosci; 2006; 29(2):177-83. PubMed ID: 16954607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.
    Vaisi-Raygani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
    Clin Biochem; 2007 Oct; 40(15):1150-6. PubMed ID: 17689519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do allelic variants of the connexin37 1019 gene polymorphism differentially predict for coronary artery disease and myocardial infarction?
    Wong CW; Christen T; Pfenniger A; James RW; Kwak BR
    Atherosclerosis; 2007 Apr; 191(2):355-61. PubMed ID: 16677656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation screening of the APOA5 gene in subjects with coronary artery disease.
    Soufi M; Sattler AM; Kurt B; Schaefer JR
    J Investig Med; 2012 Oct; 60(7):1015-9. PubMed ID: 22914599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism of apolipoprotein A5 is a risk factor for cerebral infarction in type 2 diabetes.
    Li X; Xu Y; Ding Y; Qin C; Dai Z; Niu L
    J Huazhong Univ Sci Technolog Med Sci; 2008 Dec; 28(6):653-6. PubMed ID: 19107359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Polymorphisms in the apolipoprotein A5 gene and apolipoprotein C3 gene in patients with coronary artery disease].
    Bi N; Yan SK; Li GP; Yin ZN; Xue H; Wu G; Chen BS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Feb; 33(2):116-21. PubMed ID: 15924804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic diversity of RANTES gene promoter and susceptibility to coronary artery disease and restenosis after percutaneous coronary intervention.
    Vogiatzi K; Voudris V; Apostolakis S; Kochiadakis GE; Thomopoulou S; Zaravinos A; Spandidos DA
    Thromb Res; 2009 May; 124(1):84-9. PubMed ID: 19201454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variations of apolipoprotein A5 gene is associated with the risk of coronary artery disease among Chinese in Taiwan.
    Hsu LA; Ko YL; Chang CJ; Hu CF; Wu S; Teng MS; Wang CL; Ho WJ; Ko YS; Hsu TS; Lee YS
    Atherosclerosis; 2006 Mar; 185(1):143-9. PubMed ID: 16054149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Association of C1019T polymorphism in the connexin 37 gene and coronary artery disease in Chinese Han population].
    Han YL; Xi SY; Zhang XL; Yan CH; Yang Y; Kang J
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(2):100-4. PubMed ID: 17418016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E gene polymorphism: effects on plasma lipids and risk of type 2 diabetes and coronary artery disease.
    Chaudhary R; Likidlilid A; Peerapatdit T; Tresukosol D; Srisuma S; Ratanamaneechat S; Sriratanasathavorn C
    Cardiovasc Diabetol; 2012 Apr; 11():36. PubMed ID: 22520940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A genetic variant c.553G > T (rs2075291) in the apolipoprotein A5 gene is associated with altered triglycerides levels in coronary artery disease (CAD) patients with lipid lowering drug.
    Bogari NM; Aljohani A; Amin AA; Al-Allaf FA; Dannoun A; Taher MM; Elsayed A; Rednah DI; Elkhatee O; Porqueddu M; Alamanni F; Khogeer SAA; Fawzy A
    BMC Cardiovasc Disord; 2019 Jan; 19(1):2. PubMed ID: 30606120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haplotype analysis of the apolipoprotein A5 gene in patients with the metabolic syndrome.
    Kisfali P; Mohás M; Maász A; Polgár N; Hadarits F; Markó L; Brasnyó P; Horvatovich K; Oroszlán T; Bagosi Z; Bujtor Z; Gasztonyi B; Rinfel J; Wittmann I; Melegh B
    Nutr Metab Cardiovasc Dis; 2010 Sep; 20(7):505-11. PubMed ID: 19692219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective evaluation of apolipoprotein M gene T-778C polymorphism in relation to coronary artery disease in Han Chinese.
    Jiao GQ; Yuan ZX; Xue YS; Yang CJ; Lu CB; Lu ZQ; Xiao MD
    Clin Biochem; 2007 Oct; 40(15):1108-12. PubMed ID: 17674965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin converting enzyme insertion/deletion polymorphism in French Canadian subjects with premature coronary artery disease.
    Wesolowska E; Marcil M; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Pathol Biol (Paris); 1998 May; 46(5):295-300. PubMed ID: 9769888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of polymorphisms in APOA5 on the plasma levels of triglycerides and risk of coronary heart disease in Jilin, northeast China: a case-control study.
    You Y; Wu YH; Zhang Y; Zhang L; Song Y; Bai W; Li Y; Yu Y; Kou C
    BMJ Open; 2018 Jun; 8(6):e020016. PubMed ID: 29866721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD14 promoter polymorphism (- 159C-->t) is not associated with myocardial infarction or coronary artery disease in patients with assumed high genetic risk.
    Haberbosch W; Unkelbach K; Schuster D; Gardemann A; Tillmanns H; Hölschermann H
    Thorac Cardiovasc Surg; 2009 Oct; 57(7):386-90. PubMed ID: 19795323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.